Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92 | 14 | 6 | 6 | 1 |
| Receivables | N/A | N/A | N/A | 5 | 16 |
| Inventories | 4 | 0 | N/A | N/A | N/A |
| Other current assets | 16 | 0 | 0 | 0 | 0 |
| TOTAL | $112 | $15 | $7 | $11 | $29 |
| Non-Current Assets | |||||
| PPE Net | 1 | N/A | N/A | 255 | 396 |
| Investments And Advances | 12 | 10 | 11 | 56 | 52 |
| TOTAL | $13 | $10 | $11 | $311 | $448 |
| Total Assets | $125 | $25 | $17 | $322 | $478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 185 | 20 | 150 | 66 | 248 |
| Accounts payable and accrued liabilities | 478 | 338 | 241 | 131 | 294 |
| Accrued Expenses | 232 | 147 | 63 | 35 | 4 |
| TOTAL | $996 | $574 | $732 | $247 | $561 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 69 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 75 | 60 | 63 | 21 |
| TOTAL | $N/A | $75 | $128 | $63 | $21 |
| Total Liabilities | $996 | $649 | $860 | $310 | $582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,089 | 46,084 | 38,784 | 9,739 | 28,020 |
| Common Shares | 69 | 46 | 34 | 9 | 0 |
| Retained earnings | -5,999 | -5,182 | -3,502 | -4,442 | -3,357 |
| Other shareholders' equity | 1 | -1 | 0 | 21 | 17 |
| TOTAL | $-871 | $-624 | $-843 | $13 | $-104 |
| Total Liabilities And Equity | $125 | $25 | $17 | $322 | $478 |